References for AlbuSorb™ PLUS
Serum/Plasma
Sovakova,Magdalena, et al. "Colchicineacutely reduces liver-secreted inflammatory and metabolic proteins inblood."European Journal ofPharmacology (2026):178725. After AlbuSorb™ PLUS depletion of Albumin &Immunoglobulins, quantitative Data Independent Acquisition (DIA) massspectrometry uncovered modulation of the serum and plasma proteome ofliver-derived components, leading to systemic metabolic and immunechanges.
Serum
FraserDD, Roy S, Kuruc M, Quintero M, Van Nynatten LR, Cepinskas G, ZhengH, Soherwardy A and Roy D (2025) Functionalmass spectrometry indicates anti-protease and complement activityincrease with COVID-19 severity . Exp.Biol. Med. 250:10308.doi: 10.3389/ebm.2025.10308
Plasmasamples
Grantz,Jillian M., et al. "Theplatelet and plasma proteome and targeted lipidome in postpartumdairy cows with elevated systemic inflammation ." ScientificReports 14.1(2024): 31240.
Whole blood, serum and plasma samples
DPX Technologies and Biotech Support Group Announce In-Market Partnership for High Throughput Proteomic Sample Prep
Serum/Plasma Samples
Biotech Support Group & Lawson Health Research Institute Enter Collaborative Research Agreement to Monitor Protease Inhibitor Function During Covid-19 Infections
Serum
Thangavelu, Bharani, et al. " Dataset of Rat and Human Serum Proteomes Derived from Differential Depletion Strategies prior to Mass Spectrometry. " Data in Brief (2020): 105657.
Application Report
AlbuVoid™ PLUS & AlbuSorb™ PLUS - Evaluating Different Windows of Observation Solves The Many Challenges of Serum Proteomics
AlbuSorb™ Product Extension combines Albumin and Immunoglobulin Depletion in a Consumable Format
References For AlbuSorb™
Cerebrospinal Fluid
Gwenael Pottiez, Pawel Ciborowski. Proteomic Profiling of Cerebrospinal Fluid Expression Profiling In Neuroscience Neuromethods.2012;64:245-270
Synovial fluid
Happonen KE, Fürst CM, Saxne T et al. PRELP protein inhibits the formation of the complement membrane attack complex.Journal of Biological Chemistry.2012;287(11):8092-100
Serum
Zheng H, Soherwardy A, Roy S, Kuruc M, Avadhani S. AlbuVoid™ Enrichment & Antibody Depletion – Tackling the Challenges of Serum Proteomics Part II. Poster reprint first presented at 26th International Molecular Med TRI-CON, March 10-15, 2019, San Francisco, CA USA
Roy, Swapan, and Matthew Kuruc. "Methods to Monitor the Functional Subproteomes of SERPIN Protease Inhibitors." Functional Proteomics. Humana Press, New York, NY, 2019. 41-54.
Dr.Swapan Roy; Amenah Soherwardy; Ravish Amin; Matthew Kuruc Biotech Support Group LLC, Monmouth Junction, NJ - Application Report. AlbuSorb™ Product Extension combines Albumin and Immunoglobulin Depletion in a Consumable Format
Holmberg R, Refai E, Höög A.Lowering apolipoprotein CIII delays onset of type 1 diabetes. Proceedings of the National Academy of Sciences.2011;108(26):10685-9.
Tang MX, Ogawa K, Asamoto M. Effects of Nobiletin on PhIP-Induced Prostate and Colon Carcinogenesis in F344 Rats Nutrition and Cancer.2011;63(2):227-33
Holmberg, Rebecka Apolipoprotein CIII and Ljungan virus in diabetes 2010. Doctoral Thesis
Lu Q, Zheng X, McIntosh T Development of different analysis platforms with LC-MS for pharmacokinetic studies of protein drugs. Analytical Chemistry.2009;81(21):8715-23
Urine
Zubiri, Irene, et al. "Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis." Journal of proteomics 96 (2014): 92-102.
Patent
Berggren, Per Olaf, Yang, Shao-Nian. 2012. Methods For Treating And/Or Limiting Development Of Diabetes.U.S. Patent 20120328630 Kind Code: A1, filed June 25, 2012, and issued December 27, 2012.